SCHEMBL4664751

SCHEMBL4664751

Cc1ccccc1CC(=O)C1=C(O)C(CC(C)C)OC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 6/20 0.43
DUSP3 P51452 3/20 0.43
CDC25A P30304 2/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SHBG P04278 1/20 0.41
PTPN1 P18031 5/20 0.38
ACP1 P24666 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
RECQL P46063 1/20 0.38
PTPN2 P17706 1/20 0.38
HPSE Q9Y251 1/20 0.38
CTBP2 P56545 1/20 0.37
CNR2 P34972 1/20 0.35
MAOB P27338 1/20 0.35
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
CASP7 P55210 1/20 0.34
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664745 0.81 CDC25B (0.41) CDC25BDUSP3CDC25AMAPTMEN1
SCHEMBL4664770 0.78 PTPN1 (0.39) CDC25BDUSP3CDC25AMAPTMEN1
SCHEMBL4665112 0.77 HPGD (0.39) CDC25BDUSP3MAPTPTPN1ACP1
SCHEMBL4662924 0.76 LMNA (0.39) CDC25BDUSP3CDC25AMAPTMEN1
SCHEMBL4664706 0.75 PTPN1 (0.49) CDC25BDUSP3CDC25AMAPTPTPN1
SCHEMBL4664973 0.75 PTPN1 (0.47) CDC25BDUSP3CDC25AMAPTPTPN1
SCHEMBL4662962 0.75 HTR2A (0.39) CDC25BDUSP3MAPTMEN1KMT2A
SCHEMBL4665125 0.75 PTPN1 (0.35) CDC25BDUSP3MAPTMEN1KMT2A
SCHEMBL4666574 0.74 PTPN1 (0.38) CDC25BDUSP3CDC25AMAPTMEN1
SCHEMBL4664755 0.73 CDC25B (0.36) CDC25BDUSP3CDC25AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US claimed
EP-1689729-A1 TETRONIC AND TETRAMIC ACIDS AS INHIBITORS OF BETA-SECREASE F. Hoffmann-La Roche AG (CH) 2006-08-16 EP claimed
WO-2005058857-A1 TETRONIC AND TETRAMIC ACIDS AS INHIBITORS OF BETA-SECREASE F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO claimed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US claimed
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US disclosed
EP-1689729-A1 TETRONIC AND TETRAMIC ACIDS AS INHIBITORS OF BETA-SECREASE F. Hoffmann-La Roche AG (CH) 2006-08-16 EP disclosed
WO-2005058857-A1 TETRONIC AND TETRAMIC ACIDS AS INHIBITORS OF BETA-SECREASE F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO disclosed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS BACE1, PSEN1, BACE2 CDC25B 3121/4885DUSP3 3878/4885CDC25A 2484/4885
US-20050119329-A1 Tetronic and tetramic acids BACE1, PSEN1, BACE2 CDC25B 3121/4885DUSP3 3878/4885CDC25A 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.